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A Proteomic Style Approach To Characterize a Grass Mix
Product Reveals Potential Immunotherapeutic Beneﬁt
Alan Bullimore, BSc, Nicola Swan, MSc, Wemimo Alawode, PhD, and Murray Skinner, PhD
Background: Grass allergy immunotherapies often consist of a mix
of different grass extracts, each containing several proteins of
different physiochemical properties; however, the subtle contribu-
tions of each protein are difﬁcult to elucidate. This study aimed to
identify and characterize the group 1 and 5 allergens in a 13 grass
extract and to standardize the extraction method.
Methods: The grass pollens were extracted in isolation and pooled
and also in combination and analyzed using a variety of techniques
including enzyme-linked immunosorbent assay, liquid chromatog-
raphy-mass spectrometry, and sodium dodecyl sulfate-polyacrylam-
ide gel electrophoresis.
Results: Gold-staining and IgE immunoblotting revealed a high
degree of homology of protein bands between the 13 species and the
presence of a densely stained doublet at 25–35 kD along with protein
bands at approximately 12.5, 17, and 50 kD. The doublet from each
grass species demonstrated a high level of group 1 and 5 interspecies
homology. However, there were a number of bands unique to spe-
ciﬁc grasses consistent with evolutionary change and indicative that
a grass mix immunotherapeutic could be considered broad spectrum.
Conclusions: Sodium dodecyl sulfate-polyacrylamide gel electro-
phoresis and IgE immunoblotting showed all 13 grasses share a high
degree of homology, particularly in terms of group 1 and 5 allergens.
IgE and IgG enzyme-linked immunosorbent assay potencies were
shown to be independent of extraction method.
Key Words: allergens, characterization, extraction, homology and
standardization, mass spectrometry
(WAO Journal 2011; 4:140–146)
Grass pollen is one of the most common and prevalentcauses of allergic symptoms and has been found to be
the sensitizing agent in at least 40% of allergic individuals
worldwide.1 Allergen exposure triggers the production of
allergen-speciﬁc IgE antibodies and the recruitment of
eosin-ophils through the action of T-cell cytokines, pre-
dominantly IL-4 and IL-5. Cross-linked allergen-speciﬁc
IgE on the surface of mast cells and basophils triggers the
release of inﬂammatory mediators such as histamine and
leukotri-enes,2,3 which cause early symptoms such as rhi-
nitis, among others.4,5
Allergen-speciﬁc immunotherapy (SIT), where the in-
dividual is repeatedly exposed to increasing amounts of
the allergen, resulting in a desensitization to the allergen, is
the only causative allergy treatment to date.6 Although the
precise underlying immunologic mechanism is yet to be fully
elucidated, an increase in the production of IgG antibodies,
particularly IgG4, has been demonstrated in parallel with
increasing antigen dose.7 A report by Vrtala and coworkers8
also showed that immunization with allergens induced block-
ing IgGl antibodies that bound to the same IgE epitopes, thus
inhibiting IgE-mediated histamine release and the associated
inﬂammatory response. Other immunologic effects described
as a result of SIT include a shift in the TH2 response typical in
allergy to TH1
9 and a reduction in the number of circulating
basophils.10
The grass family (Poaceae) consists of more than
10,000 species and during the last few decades many
species have been investigated intensively for allergenicity.
The majority of proteins recognized as the major causes of
grass allergy have been identiﬁed in the Pooideae sub-
family found in temperate zones.11 Other allergens have
been identiﬁed in the Chloridoideae and Panicoideae sub-
families12 of subtropical regions. To date, 13 groups of
grass pollen allergens have been identiﬁed from different
grass species,11 of which groups 1 and 5 are considered
major allergens. Both group 1 and group 5 allergens are
expressed in several grass species and IgEs against these
proteins represent up to 80% or more of the speciﬁc IgE in
patients allergic to grass.13 These allergens have been con-
served in the Pooideae species11 and hence share a high
degree of homology in their amino acid sequences, some-
times up to 90% and 75% for group 1 and group 5,
respectively.13 However, molecular differences resulting
in isoforms of these 2 allergens in different species have
been observed.14,15 This observation, taken together with
the involvement of minor allergens, the nonuniform geo-
graphical distribution of grasses, and the polyexposure of
each individual to multiple pollens, strongly suggests that
there will be heterogeneity in the sensitization proﬁle of
each patient. Thus, immunotherapy with mixed extracts
may ensure that different patients beneﬁt equally.
However, controversy exists on the beneﬁts of an
immunotherapeutic mix containing more than 5 grass species;
in addition, the reproducibility of extracting different pollen
species in combination has been debated.16 Hence, this study
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investigated a sublingual and subcutaneous immunotherapeu-
tic consisting of 13 different grass species from the Pooideae
subfamily (Table 1). The effects of extracting the grass pol-
lens in isolation and in combination were studied by analyz-
ing their respective total protein content, IgE reactivity, and
chromatographic proﬁles. The suspected group 1 and group 5
allergens were isolated and a proteomics style approach was
used to match peptide sequence to online databases.
MATERIALS AND METHODS
Grass Pollen Extracts
Grass pollens were purchased from Allergon (Ängel-
holm, Sweden) and Pharmallerga (Lisov, Czech). The com-
bined extracts were prepared by roller mixing 2.31 g of pollen
(from each of the 13 grass species) in 600 mL of extraction
buffer (Pool A). This was followed by centrifugation at 3000g
for 10 minutes and the supernatant was clariﬁed by passage
through a 0.2-mm syringe ﬁlter (Millipore, Watford, UK).
Five percent single pollen extracts were prepared by roller
mixing 2.31 g of pollen in 46.15 mL of phosphate extraction
buffer (1 mM Na2HPO4, 271.89 nM KH2PO4, 8.56 mM NaCl,
0.5% phenol, 2 M HC1, 2 M NaOH) at 2–88C for 18 hours
and clarifying as described for pool A. One milliliter of each
single pollen extract was then combined to give a pool of 13
grass extracts (pool B) and the remainder of the single pollen
extracts retained for testing.
Sodium Dodecyl Sulfate-Polyacrylamide
Gel Electrophoresis (SDS-PAGE)
Aliquots of the pollen extracts (single pollen extracts,
pool A and pool B) were denatured by heating at 1008C for
2 minutes in sample buffer containing sodium dodecyl sul-
fate. The proteins were then resolved on a 10%–20% Tris-
HC1 Criterion gel (Bio-Rad, Hemel Hempstead, UK) and the
gels electrophoresed according to the manufacturer’s proto-
col. The separated proteins were transferred onto polyvinyldi-
ﬂuoride membranes using a semidry apparatus (Bio-Rad).
The membranes were either stained with colloidal gold stain
(BioRad) for total protein proﬁle or used for Western blotting.
IgE and IgG Western Blotting
The membranes were blocked with 10% milk diluent
(KPL, Middlesex, UK) prepared in Dulbecco phosphate
buffered saline (DPBS). The membranes were then washed
with DPBS–0.3% Tween 20 and incubated overnight at 48C
with sera. IgE sera (n . 2) from individuals allergic to grass
was screened by PlasmaLab (Everett, WA) and evaluated in-
house before pooling was diluted 1:5 (vol/vol in 5% milk
diluent) or an international standard IgE sera sourced from
the Center for Biologies Evaluation and Research (CBER;
n ¼ 5) was used. Alternatively, IgG sera raised in rabbits
immunized with puriﬁed grass extracts diluted 1:1000 (vol/
vol) were used. The membranes were washed again and in-
cubated with biotinylated goat anti-human IgE or goat anti-
rabbit IgG (diluted 1:1000) for 1 hour at room temperature.
After being washed, the membranes were incubated with
streptavidin peroxidase (Sigma, Poole, UK) diluted 1:1000
for another hour at room temperature. After the ﬁnal wash,
the color was developed with the addition of 1 component
3,39,5,59-tetramethylbenzidine membrane peroxidase sub-
strate (KPL). The color reaction was stopped by washing
the membranes with distilled water.
Isoelectric Focusing (IEF)
For IEF, ampholine PAG plate gels (pH 3.5–9.5), pI
standard (pH 4.7–10.6; Pharmacia Biotech AB), and broad
range pI standard (pH 3–10; GE Healthcare, Buckingham-
shire, UK) were used. The gel was mounted onto a Multiphor
II electrophoresis unit cooling system (Pharmacia Biotech
AB) set at 78C and 20 mL of each pollen extract and 5 mL
of pI standards were focused for 500 V, 25 mA, and 10 W for
30 minutes, followed by 2000 V, 20 mA, and 25 W and
ﬁnally 2000 V, 20 mA, and 30 W. Immediately after IEF,
the gel was ﬁxed, washed, and visualized with Coomassie
Brilliant Blue G250. The gel was destained and scanned.
IgE and IgG ELISA Potency Determination
Potency ELISAs were performed to measure the IgE
and IgG reactivity of the 2 types of grass extracts (ie, pools A
and B). IgE reactivity was determined by competing solid-
phase grass extract with soluble samples for IgE antibodies.
Brieﬂy, microtitre plates (Corning) were incubated overnight
at 2–88C with a freeze-dried 12 grass extract in DPBS con-
taining magnesium chloride and calcium chloride. The plates
were washed with DPBS-Tween 20 and blocked with 1%
bovine serum albumin solution in coating buffer. After wash-
ing, samples were then loaded on, followed by human anti-
grass IgE sera, and incubated for 2 hours with continuous
shaking at 208C. The plates were washed once again and
incubated with goat anti-human IgE horseradish peroxidase.
The color was then developed by adding 3,39,5,59-tetrameth-
ylbenzidine peroxidase substrate. The reaction was stopped
with 1 M orthophosphoric acid and the plates read at 450 nm.
IgG reactivity was determined by measuring the Lol p 1
contentdthe major allergen of rye grass pollen found to be
distributed between other grass speciesd17 using an in-house
competition ELISA in conjunction with time-resolved
TABLE 1. Pollens in the 13 Grass Extract
Grass Species Abbreviation
Colonial Bent Agrostis capillaris Agr ca
Brome Bromus inermis Bro i
Orchard Dactylis glomerata Dac g
Crested Dogstail Cynosurus cristatus Cyn cr
False Oat Arrhenatherum elatius Arr e
Fescue Meadow Festuca pratensis Fesp
Foxtail Meadow Alopecurus pratensis Alo p
Meadow Poa pratensis Poa p
Rye Lolium perenne Lol p
Timothy Phleum pratense Phl p
Sweet Vernal Anthoxanthum odoratum Ant o
Yorkshire Fog Holcus lanatus Hol I
Cultivated Rye Secale cereale Sec c
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ﬂuorescence. Brieﬂy, microtitre plates (Thermo Fisher Scien-
tiﬁc, UK) were coated with 50 mg/mL staphylococcal protein-
A in DPBS. After the plate was washed with DPBS–0.1%
Tween 20, the wells were incubated with rabbit anti-Lol p 1
serum at 378C for 1 hour. This was followed by the addition
of a mixture of grass extract and Europium-labeled puriﬁed
Lol p 1 and incubated at 378C for 1.5 hours. The plate was
washed again and the reaction developed with enhancement
solution. The plate was then read using a time-resolved ﬂuo-
rescence spectrometer (PerkinElmer, Waltham, MA).
Trypsin In-Gel Digestion and Peptide
Extraction for Proteomic Style Assessment
The heavily stained protein doublet at 25–37 kD was
excised as 2 singlets from Coomassie blue-stained SDS-
PAGE protein proﬁles of each of the 13 grasses and in-gel
digestion carried out with trypsin. Gel pieces were washed
twice with 50 mL of acetonitrile (ACN) and reduced with 50;
uL of 10 mM dithiothreitol/25 mM NH4HCO3 at 568C for
1 hour. The dithiothreitol was removed and cysteines were
alkylated in the dark with 50 mL of 55 mM iodoacetimide/
25 mM NH4HCO at room temperature for 45 minutes before
the addition of trypsin. The iodoacetimide was removed,
and the gel pieces were washed with ACN and dried for
30 minutes in a Speedivac. Proteins were digested with
5 mL of 25 ng/mL trypsin along with 45 mL of 25 mM
NH4HCO3 on ice for 45 minutes followed by overnight in-
cubation at 378C or a minimum of 4 hours at 488C. The re-
action was terminated with triﬁuoroacetic acid to 1% vol/vol
and the supernatant retained.
Fifty microliters of 20 mM NH4HCO3 was added to the
gel pieces before sonication for 5 minutes and then allowed to
stand for 20 minutes at room temperature before centrifuging;
this step was repeated twice and the retained supernatants
were pooled together. The sample was then acidiﬁed with
50 mL of 5% formic acid/50% ACN and concentrated down
to approximately 25 mL using a Speedivac. The extracted
pep-tides were then fractionated and separated on a Pep-
Map100 C18 reverse-phase column (Dionex, Sunnyvale,
CA) using an Ultimate U3000 nano-LC system (Dionex)
equipped with a 20-mL injection loop. Peptide separation
was performed using a linear gradient from 100% solvent
A (97.9% water, 2% ACN, 0.1% formic acid) to 56% solvent
B (90% ACN, 9.9% water, and 0.1% formic acid) at a ﬂow
rate of 350 nL/min.
Tandem Mass Spectrometry and
Interpretation of MS/MS Data Sets
The eluted peptides were directly analyzed by tandem
mass spectrometry using an LTQ Orbitrap FT-MS (Thermo
Scientiﬁc) ﬁtted with a nanospray ion source and using
stainless steel nano-bore emitters (both Proxeon Biosystems,
Odense, Denmark). Tandem mass spectra were collected in
a data-dependent fashion by collecting one full MS scan (m/z
range: 375-1800) followed by MS/MS spectra of the 5 most
abundant precursor ions (in ion trap), both in the Orbitrap
detector. The resulting MS/MS spectra were then used to
search against an annotated UniProtKB/Swiss-Prot database
(release version 57) using the SEQUEST protein identiﬁca-
tion algorithm as implemented within Bio Works v3.3
(Thermo Scientiﬁc). Stringent ﬁltering criteria used for posi-
tive protein identiﬁcations were Xcorr values . 1.9 for 11
spectra, 2.2 for 12 spectra, and 3.75 for 13 spectra and
a delta correlation cutoff of 0.1.
Reverse-Phase and
Size-Exclusion Chromatography
The proteins within the pooled extracts were separated
and analyzed with both reverse-phase and size-exclusion
chromatography. The former was on a Jupiter C4 300 Ä col-
umn (Phenomenex, Cheshire, UK) with an injection volume
of 10 mL using a 0.1 M phosphate buffer mobile phase (so-
dium dihydrogen phosphate monohydrate and disodium hy-
drogen phosphate anhydrous; pH 6.86 0.5) and a ﬂow rate of
1 mL/min. The size exclusion was carried out on a BioSep
4000 column (Phenomenex) using the same mobile phase
described above. The following aqueous standards were dis-
solved in the mobile phase to give a 2 mg/ml solution: dextran
blue, thyroglobulin, apoferritin, B-amylase, albumin, and
carbonic anhydrase (Sigma).
RESULTS
SDS-PAGE and Western Blot
The pooled grass extracts exhibited identical total
protein proﬁles containing the same number of bands of
similar staining intensity while also highly comparable with
the 13 single grass extracts, each of which separated into at
least 12 bands (Fig. 1A). Both the CBER and in-house grass
standards were also comparable and separated into at least 17
bands in the 10–100 kD range. Western blotting of the pro-
teins with an in-house batch of IgE sera (Fig. 1B) and FDA/
CBER-supplied IgE sera (Fig. 1C) demonstrated the aller-
genic proﬁles to be highly comparable and also with the total
protein. A prominently stained doublet in the 25–37 kDa
range was present in all samples along with bands of
w12.5, 17, and 50 kDa.
Figure 1B, C additionally highlights the presence of the
considered major allergens Phi p 1 and Phi p 513 in each of
the 13 grass species and both pooled extracts. However,
signiﬁcant minor allergens are evident with molecular
weights ranging from 15 to 50 kDa.
Isoelectric Focusing
The grass pollen extracts (sample identities found in
Table 2) were also analyzed on a precast IEF gel (Fig. 2) and
each exhibited a highly comparable proﬁle especially in the
3.5-5.85 pi range. Similar to the SDS-PAGE, both pools A
and B separated into multiple bands of identical isoelectric
points.
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IgE and IgG ELISA Potency Determination
The 2 pooled grass extracts when assayed on IgE and
IgG reactivity ELISAs returned highly comparable potencies
(Table 3; QAU/mL [quality assurance unit - arbitrary in-
house potency unit]).
Chromatograms
The size-exclusion and reverse-phase chromatograms
of the pooled extracts overlay very closely with identical
peaks and troughs (Fig. 3A, B).
Mass Spectrometry
The densely stained protein bands between 25 and 37
kDa molecular weight (MW) were trypsin digested and
subjected to liquid chromatography-mass spectrometry (LC-
MS). The resulting peptides were identiﬁed by comparing the
MS/MS spectra generated against that of known sequences in
the SEQUEST database. The tryptic digests yielded multiple
peptides from each grass species with the exception of
Cultivated Rye, which yielded only one peptide. A total of
157 peptides were analyzed by LC-MS and compared against
SEQUEST, returning a total of 156 matches (data not shown).
At least one peptide from each of the 13 species demonstrated
homology to Hol l 1, with the exception of the Cultivated Rye
peptide, which showed homology only to Rye grass. The
FIGURE 1. Total protein and IgE
reactivity proﬁles of the grass pollen
extracts. A, Proteins gold-stained or
Western-blotted with (B) ATL IgE sera
or (C) CBER IgE sera. Lane 1, molecular
weight marker; lane 2, CBER grass
standard; lane 3, in-house grass
standard; lanes 4-16, single pollen
extracts in the order listed in Table 1;
lane 17, pollens extracted singly and
pooled; lane 18, pollens extracted
together.
TABLE 2. Sample Identity of the IEF Gel
Lane No. Sample Identity Lane No. Sample Identity
1 Marker 9 Meadow
2 Cultivated rye 10 Rye Grass
3 Brome 11 Bent
4 Orchard 12 Sweet Vernal
5 Dogstail 13 Yorkshire Fog
6 Oat 14 Timothy
7 Fescue 15 PoolB
8 Foxtail 16 Pool A
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peptide sequences that yielded a match against different spe-
cies are summarized in Table 4.
DISCUSSION
In allergen-speciﬁc immunotherapy, patients allergic to
grass pollen are often treated with immunotherapeutics
consisting of extracts prepared from a mixture of grasses.
The composition of allergens in extracts can vary depending
on the allergen source, manufacturing process, and storage
conditions. Variability can be controlled to a degree by using
reproducible extraction and processing procedures. Therefore,
in this study, we investigated the impact of extracting 13
different grass pollens together. In addition, we assessed
interspecies variability for both major group 1 and group 5
allergens (Table 1) present in the 13 grass immunotherapeutic
extract. Molecules extracted from each of these major aller-
gens were characterized using a combination of different an-
alytical methods.
Grass pollens from 13 different pollens when extracted
together exhibited indistinguishable gold-stained and IgE
reactivity proﬁles to the pollens extracted singly and com-
bined when separated on SDS-PAGE, both resolving into at
least 24 protein bands spanning the 10–100 kD range. The
IEF Coomassie Brilliant Blue G250-stained proﬁles also
yielded similar results. The size-exclusion and reverse-phase
chromatographic proﬁles of the pooled extracts (Fig. 3 A, B)
show that they contain proteins of the same size and hydro-
phobicity in the same proportion. Furthermore, ELISA
showed the 2 pools to be of highly comparable IgE and
IgG reactivities, indicating that extracting the pollens in com-
bination does not negatively affect epitope recognition by
antibodies. These observations demonstrate the equivalence
of extracting grass pollens in combination or in isolation and
pooling.
SDS-PAGE and immunoblotting with IgE sera demon-
strated the presence of highly similar molecular weight
proteins among the grasses, indicating that the grasses share
signiﬁcant homology. Interspecies IgE cross-reactivity was
demonstrated in Fig. 1C, which shows that all 13 grass spe-
cies reacted with the 5-grass CBER-supplied sera. These ﬁnd-
ings support other studies that report the presence of a high
degree of shared epitopes among these grasses using mono-
clonal antibodies.18,19
Our results also reveal the presence of a densely stained
protein doublet at 25–37 kDa in all 13 grasses and densely
stained proteins at approximately 12.5, 17, and 50 kDa. With
use of a proteomics style approach, tryptic digests and LC-
MS analysis of the 25–35 kDa doublet as singlets showed the
higher and lower molecular weight bands in this doublet to be
group 1 and group 5 homologs, respectively (Table 4). With
the exception of the Cultivated Rye extract, the higher mo-
lecular weight bands of this doublet from all 13 species dem-
onstrated homology to Hol l 1, Phl p 1, and Pha a 1 (Canary
Grass; Phalariscanariensis) and to a lesser degree Lol p 1,
whereas the lower molecular weight bands demonstrated ho-
mology to the Pha a 5, Phl p 5, and Lol p 5. This strongly
suggests the excised singlets to be group 1 and group 5 aller-
gens. The discovery of such a high level of interspecies ho-
mogeneity is not surprising as members of the Pooideae grass
family are considered to be homogenous.13 The presence of
the group 1 and group 5 doublet in all 13 grass extracts
signiﬁes the importance of standardization of common aller-
gens to ensure that the allergens responsible for eliciting an
allergic response are always present in the immunotherapeutic
extract.
However, our results also reveal heterogeneity in the
total protein and allergenic proﬁles of the grasses both in
terms of molecular weight and staining intensity. For
example, in addition to the prominently stained doublet
within the 25–37 kDa range, some of the grasses also contain
a similarly stained third and sometimes fourth band at approx-
imately 25 and 27 kDa. A similar observation is evident in the
lower molecular weight region where all extracts have
a densely gold-stained 10 kDa protein band; however, in
some extracts this band is present as a doublet. Furthermore,
in the IgE immunoblots a triplet of approximately 10 kDa
bands is present in some extracts (Fig. 1). This variation in
protein content suggests that each grass species contributes
unique properties to an immunotherapeutic mix. As yet un-
identiﬁed, these bands may be due to the presence of multiple
isoforms of the same allergen because of alternative splicing
or post-transcriptional modiﬁcation. In 2009, Chabre et al20
demonstrated the presence of several primary sequence var-
iants, glycosylated forms, and hence several isoforms of
TABLE 3. IgE and IgG Potency of the Pooled Grass Extracts
(QAU/mL)
Sample IgE Potency IgG Potency
Pool A 109.1 1346
111.2 1431
109.9 1566
Pool B 99.08 1014
107.1 1471
116.5 2074
FIGURE 2. Coomassie Blue-stained IEF analysis of grass pollen
extracts (sample identities as in Table 2).
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group 1 and group 5 allergens within each grass species.
Other studies have also reported quantitative and qualitative
differences between the allergen content of Pooideae spe-
cies.21–23
Different sensitization proﬁles may mean minor aller-
gens are more relevant immunotherapeutic targets in certain
patients; hence, standardization based solely on major
allergens may be limited in providing data for a wider
allergen-sensitive population. A recent study reporting on
the efﬁcacy of SIT found that, of 746 patients, 73% sensitized
to the major allergen beneﬁted from treatment; however, only
16% of those sensitized to the minor allergens reported the
same beneﬁt.24 Although relatively lower, the ﬁgure reveals
the beneﬁt of the inclusion of minor allergens. Furthermore,
the immunoblots presented here demonstrate that the minor
allergens are different across different grass species and this is
TABLE 4. Peptide Homology Generated From LC-MS
Grass MWof Digested Segment (kDa) Peptide Peptide Homology
Bent 33.9 K.STWYGKPTGAGPK.D Hol l 1 Lol p 1 Pha a 1 Phl p1
K.YAVFEAALTK.A Lol p 5a Phl p 5b
Yorkshire Fog 33.5 K.YPDGTKPTFHVEK.G Hol l1 Pha a 1
Brome 31.7 K.YAVFEAGLTK.A Pha a5.1 Pha a5.3 Pha a5.4
K.GSNPNYLALLVK.Y Hol l1 Pha al Phl p1
Dogstail 29.4 K.STWYGKPTGAGPK.D Hol l1 Lol pi Pha al Phl p1
K.YDAYVATLSEALR.I Phl p5a
Cultivated Rye 26.6 K.FTVFESAFNK.A Lol p5a
False Oat 32.7 K.GKDKWIELK.E Hol l1 Lol p1 Pha al Phl p1
28.6 K.GSNPNYLALLVK.Y Hol l1 Pha al Phl pl
K.FTVFEGAFNK.A Pha a 5.1 Pha a 5.3 Pha a 5.4
Fescue 32.6 K.GSNPNYLALLVK.Y Hol l1 Pha al Phl pl
K.TFVETFGTATNK.A Lol p5b
28.3 K.YV N/D GDGDVVAVDIK.E Lol p1 Pha al Phl pl
K.IAATAANAAPTNDK.F Lol p5a
Foxtail 32 K.GSNPNYLALLVK.Y Hol l1 Pha al Phl p5b
29 K.IPAGELQIIDKIDAAFK.V Phl p5b
Meadow 33.9 K.GSNPNYLALLVK.Y Hol l1 Pha al Phl p5b
29.5 K.YAVFEAALTK.A Lol p5a Phl p5b
Orchard 33 K.GSNPNYLALLVK.Y Hol l1 Pha al Phl pl
K.LAYEAAQGATPEAK.Y Lol p 5b
Rye 33 K.GSNPNYLALLVK.Y Hol l1 Pha al Phl pl
K.LAYEAAQGATPEAK.Y Lol p 5b
28.8 K.YAVFEAALTK.A Lol p5a Phl p5b
Sweet Vernal 33.8 K.GSNPNYLALLVK.Y Hol l1 Pha al Phl p1
K.YV N/D GDGDVVAVDIK.E Lol p1 Pha a 1 or Phl p 1 (if N)
30 R.VIAGALEVHAVK.P Lol p5a Phl p5b
Timothy 32 K.GSNPNYLALLVK.Y Hol l 1 Pha a 1 Phlp 1
27.7 K.YV N/D GDGDVVAVDIK.E Lol p1 Pha al or Phl pl (if N)
K.YAVFEAALTK.A Lol p5a Phi p5b
N/D means Asn (N) to Asp (D) deamidation possible.
FIGURE 3. A, Size-exclusion chromatogram and (B) reverse-phase chromatogram.
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supported in ﬁndings by Hrabina et al who show that minor
allergens show sequence identity, but little cross-reactivity
with group 1 allergens.13 A therapeutic product that contains
a broad spectrum of efﬁcacy that the inclusion of minor aller-
gens may confer may be considered beneﬁcial to the pool of
patients sensitized to those minor allergens such as Phl p 7
and Phl p 12 while providing equal beneﬁt to patients sensi-
tized to the major allergens Phl p 1 and Phl p 5 as shown in
Fig. 1B, C.
Another important factor to consider in patient sensiti-
zation proﬁles is highlighted by a recent study that reported
an outbreak of adverse reactions to olive immunotherapy
because of the high concentrations of a minor olive allergen
Ole e 9, in certain batches of olive pollen extracts.25 Patients
living in olive-growing areas were found to be highly sensi-
tized to Ole e 9 compared with those outside of these regions
where Ole e 1, a major allergen, is the relevant allergen.
Occurrences such as this further emphasizes the need for
allergen standardization as a variation in protein content
may lead to adverse events or a reduction in the reactivity/
immulnotherapeutic effect. This also indicates an immuno-
therapeultic based on a 13-grass mixture may allow desensi-
tization to a broader range of epitopes than one with less as it
better reﬂects natural exposure conditions.
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